![](/img/cover-not-exists.png)
868PSafety of new androgen receptor inhibitors (ARi) in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC): A network meta-analysis of randomized controlled trials (RCT)
Altavilla, A, Maio, M Di, Tucci, M, Lolli, C, Schepisi, G, Buttigliero, C, Vignani, F, Giorgi, U DeVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz248.025
Date:
October, 2019
File:
PDF, 78 KB
2019